EastPharma Ltd (UK) – Capital increase in Deva Holding has been approved by the Capital Market Board

Capital increase in Deva Holding has been approved by the Capital Market Board

Capital increase in Deva Holding has been approved by the Capital Market Board EASTPHARMA LTD.

EastPharma (EAST LI), a company active in manufacturing and marketing of branded generic and in-licensed pharmaceutical products in Turkey and other regional markets, informs that the capital increase in Deva Holding A.S. has been approved by the Capital Market Board of Turkey and subsequently Deva Holding A.S.’s stock split has been realized as of 11.02.2010 on the Istanbul Stock Exchange.

Within the registered capital ceiling amounting to 500,000,000 Turkish Liras of Deva Holding A.S., one of the subsidiaries of EastPharma, the application regarding the increase of the issued capital through rights issues from 144,000,000 Turkish Liras to 180,000,000 Turkish Liras was approved by the Capital Market Board on 01.02.2010. The rights to purchase shares through rights issues shall be traded in the Rights Market between 11.02.2010-25.02.2010. The share prices shall be made available for 1 Kurus for each share having a nominal value of 1 Kurus. Deva minority shareholders can participate to the capital increase between the dates 11.02.2010-25.02.2010 for a period of fifteen days.

The base prices of the stocks that is traded ‘Newly’ as of 11.02.2010 as the references are stated herein below:
The base price of the ‘Old’ stocks: 3.62 Turkish Liras
The base price of the ‘New’ stocks: 3.10 Turkish Liras

EastPharma S.a.r.l. made the payment of 29,608,075.34 Turkish Liras to Deva Holding regarding the capital increase of Deva Holding, so that the shares held by EastPharma S.a.r.l totalling to 82.24% in Deva Holding does not change.

09:34 CET 16-02-2010 /HUGIN /Source: EastPharma Ltd /LSE: EAST.L /ISIN: US27778Q2049